Activity value 72china Supplier,Last transaction date:
2025-12-05
Overview
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for beijing dc pharma co ltd. from 2024 to 2025.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2025, the company has completed 5 transactions, with a transaction quantity of 432 and a transaction weight of 89.
YearTransactionsQuantityWeight
2024000
2025543289
Bill of lading data
<
1/15
>
Trade date
2025/12/05
B/L No.
cec2025dl002148
Suppliers
beijing dc pharma co ltd.
Buyers
trasdial s.a.
POLs
pvg-shanghai pudong international airport
PODs
quito
Suppliers
beijing dc pharma co ltd.
Buyers
trasdial s.a.
POLs
pvg-shanghai pudong international airport
PODs
quito
Supply area
China
Purchas area
Ecuador
Weight
0.338kg
Amount
35.193
Hs code
9018390000
Product tags
sheath
Product description
Minicap with Povidone Iodine
Expand
Trade date
2022/12/13
B/L No.
——
Suppliers
beijing dc pharma co ltd.
Buyers
ooo laxisam
POLs
——
PODs
——
Supply area
China
Purchas area
Uzbekistan
Weight
10600kg
Amount
127200
Hs code
3004900002
Product tags
equipped with fixed dose drug
Product description
MEDICINES: FDP-LACHISAM, INTERNATIONAL (SODIUM FRUCTOSE DIPHOSPHATE), POWDER FOR SOLUTION FOR INFUSION 5G NO. 1 (VIALS) (SERIES U-210716 F), COMPLETE WITH SOLVENT, WATER FOR INJECTION 50 ML NO. 1 SERIES (U-210126 W), TOTAL 42400
Expand
Trade date
2022/12/13
B/L No.
——
Suppliers
beijing dc pharma co ltd.
Buyers
ooo lahisam
POLs
——
PODs
——
Supply area
China
Purchas area
Uzbekistan
Weight
10600kg
Amount
127200
Hs code
3004900002
Product tags
equipped with fixed dose drug
Product description
MEDICINES: FDP-LACHISAM, INTERNATIONAL (SODIUM FRUCTOSE DIPHOSPHATE), POWDER FOR SOLUTION FOR INFUSION 5G NO. 1 (VIALS) (SERIES U-210716 F), COMPLETE WITH SOLVENT, WATER FOR INJECTION 50 ML NO. 1 SERIES (U-210126 W), TOTAL 42400
Expand
Trade date
2022/02/08
B/L No.
——
Suppliers
beijing dc pharma co ltd.
Buyers
тоо фирма аделина
POLs
——
PODs
——
Supply area
Other
Purchas area
Kazakhstan
Weight
42826
Amount
49733.08
Hs code
3004900002
Product tags
tablets,packaging
Product description
1. НАТРИЯ ХЛОРИД РАСТВОР ДЛЯ ИНФУЗИЙ В ПОЛИПРОПИЛЕНОВОМ ФЛАКОНЕ 0,9% 200МЛ, :; ПРОИЗВОДИТЕЛЬ: ANHUI DOUBLE-CRANE PHARMACEUTICAL CO.LTD.; ТОВАРНЫЙ ЗНАК: ОТСУТСТВУЕТ; МАРКА ТОВАРА: "PHARMADEL"; , КОЛИЧЕСТВО: 180320.00 ШТ;
Expand
Trade date
2022/02/08
B/L No.
——
Suppliers
beijing dc pharma co ltd.
Buyers
тоо фирма аделина
POLs
——
PODs
——
Supply area
Other
Purchas area
Kazakhstan
Weight
15618
Amount
18136.91
Hs code
3004900002
Product tags
tablets,packaging
Product description
1. НАТРИЯ ХЛОРИД РАСТВОР ДЛЯ ИНФУЗИЙ В ПОЛИПРОПИЛЕНОВОМ ФЛАКОНЕ 0,9% 200МЛ, :; ПРОИЗВОДИТЕЛЬ: ANHUI DOUBLE-CRANE PHARMACEUTICAL CO.LTD.; ТОВАРНЫЙ ЗНАК: ОТСУТСТВУЕТ; МАРКА ТОВАРА: "PHARMADEL"; , КОЛИЧЕСТВО: 65760.00 ШТ;
Expand
Trade date
2022/02/08
B/L No.
——
Suppliers
beijing dc pharma co ltd.
Buyers
тоо фирма аделина
POLs
——
PODs
——
Supply area
Other
Purchas area
Kazakhstan
Weight
7015
Amount
6729.63
Hs code
3004900002
Product tags
tablets,packaging
Product description
1. НАТРИЯ ХЛОРИД РАСТВОР ДЛЯ ИНФУЗИЙ В ПОЛИПРОПИЛЕНОВОМ ФЛАКОНЕ 0,9% 250МЛ, :; ПРОИЗВОДИТЕЛЬ: ANHUI DOUBLE-CRANE PHARMACEUTICAL CO.LTD.; ТОВАРНЫЙ ЗНАК: ОТСУТСТВУЕТ; МАРКА ТОВАРА: "PHARMADEL"; , КОЛИЧЕСТВО: 24400.00 ШТ;
Expand
Trade date
2022/02/08
B/L No.
——
Suppliers
beijing dc pharma co ltd.
Buyers
тоо фирма аделина
POLs
——
PODs
——
Supply area
Other
Purchas area
Kazakhstan
Weight
21413
Amount
23718.2
Hs code
3004900002
Product tags
tablets,packaging
Product description
1. НАТРИЯ ХЛОРИД РАСТВОР ДЛЯ ИНФУЗИЙ В ПОЛИПРОПИЛЕНОВОМ ФЛАКОНЕ 0,9% 200МЛ, :; ПРОИЗВОДИТЕЛЬ: ANHUI DOUBLE-CRANE PHARMACEUTICAL CO.LTD.; ТОВАРНЫЙ ЗНАК: ОТСУТСТВУЕТ; МАРКА ТОВАРА: "PHARMADEL"; , КОЛИЧЕСТВО: 90160.00 ШТ;
Expand
Trade date
2022/02/08
B/L No.
——
Suppliers
beijing dc pharma co ltd.
Buyers
тоо фирма аделина
2ooo lahisam
uzbekistanbuyer,they trade on 2022-12-13
1216%
>
3ooo laxisam
uzbekistanbuyer,they trade on 2022-12-13
1216%
>
4trasdial s.a.
ecuadorbuyer,they trade on 2025-12-05
56.67%
>
5ооо лахисам
mongoliabuyer,they trade on 2021-03-19
45.33%
>
Products
Total 3
ProductsTransactionsPerDetail
tablets 1954.29%>
packaging 1954.29%>
equipped with fixed dose drug 1645.71%>
Hscode rank
Total 4
HSCode NameTransactionsPerDetail
HS 300490000235100%>
Trading Area
Total 3
AreaTransactionsPerDetail
kazakhstan4256%>
uzbekistan2837.33%>
ecuador56.67%>
Port statistics
Total 1
Port NameTransactionsPerDetail
pvg-shanghai pudong international airport56.67%>
beijing dc pharma co ltd. is china Supplier,
and primarily engages in the import and export business of products such as tablets,packaging,equipped with fixed dose drug.
According to the 52wmb.com global trade database, as of 2025-12-05, the company has completed 75 international trades,
with its main trading regions covering kazakhstan,uzbekistan,ecuador etc.
The core products include HS3004900002 etc,
often transported via pvg-shanghai pudong international airport etc,
and its main trading partners are тоо фирма аделина,ooo lahisam,ooo laxisam.
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on beijing dc pharma co ltd. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.